| Target and Pathway |
Top |
| Target(s) |
Fibronectin (FN1) |
Target Info
|
Inhibitor |
[2] |
|
KEGG Pathway
|
PI3K-Akt signaling pathway
|
|
Focal adhesion
|
|
ECM-receptor interaction
|
|
Regulation of actin cytoskeleton
|
|
Bacterial invasion of epithelial cells
|
|
Amoebiasis
|
|
Pathways in cancer
|
|
Proteoglycans in cancer
|
|
Small cell lung cancer
|
|
NetPath Pathway
|
IL4 Signaling Pathway
|
|
TGF_beta_Receptor Signaling Pathway
|
|
Panther Pathway
|
Integrin signalling pathway
|
|
Pathway Interaction Database
|
Beta1 integrin cell surface interactions
|
|
Beta3 integrin cell surface interactions
|
|
Angiopoietin receptor Tie2-mediated signaling
|
|
Alpha9 beta1 integrin signaling events
|
|
Integrins in angiogenesis
|
|
Syndecan-4-mediated signaling events
|
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
|
Beta5 beta6 beta7 and beta8 integrin cell surface interactions
|
|
Syndecan-2-mediated signaling events
|
|
VEGFR3 signaling in lymphatic endothelium
|
|
Alpha4 beta1 integrin signaling events
|
|
Reactome
|
Platelet degranulation
|
|
Degradation of the extracellular matrix
|
|
Fibronectin matrix formation
|
|
Cell surface interactions at the vascular wall
|
|
Molecules associated with elastic fibres
|
|
Integrin cell surface interactions
|
|
Syndecan interactions
|
|
Non-integrin membrane-ECM interactions
|
|
ECM proteoglycans
|
|
Integrin alphaIIb beta3 signaling
|
|
GRB2:SOS provides linkage to MAPK signaling for Integrins
|
|
p130Cas linkage to MAPK signaling for integrins
|
|
MAP2K and MAPK activation
|
|
WikiPathways
|
Senescence and Autophagy in Cancer
|
|
Regulation of Actin Cytoskeleton
|
|
Inflammatory Response Pathway
|
|
TGF beta Signaling Pathway
|
|
Focal Adhesion
|
|
miRNA targets in ECM and membrane receptors
|
|
Extracellular matrix organization
|
|
Nanoparticle-mediated activation of receptor signaling
|
|
Integrin cell surface interactions
|
|
Integrin alphaIIb beta3 signaling
|
|
Cell surface interactions at the vascular wall
|
